In addition to its seven Bay Area clinics that offer in-person care, the startup has a mobile app through which patients can conduct video visits or get treated for conditions by messaging Carbon providers.
GreatPoint Ventures led the Series B round for the San Francisco-based startup, and Tarsadia Investments, Crosslink Capital and Uncork Capital also participated.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
The company, Trusted Health, offers a technology employment platform that nurses can use to find flexible job opportunities as well as permanent staff positions.
Through the Splunk controlled substance monitoring platform, NewYork-Presbyterian can see if medications are being diverted for potentially illegitimate purposes, like a doctor prescribing a medication to a patient not currently in the hospital.
The San Francisco-based company, which was founded in 2014, offers a solution that lets organizations integrate data from various sources (like EMR systems and claims files) into a single platform.
Based in San Francisco, Hinge Health provides a digital solution aimed at helping patients with musculoskeletal pain.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
John Hammergren, who has served as the company's CEO for nearly 20 years, will retire next year, and COO Brian Tyler will take his place.
The company, GYANT, allows patients to utilize its AI-powered chatbot. The patient is then passed to a human medical provider who can deliver a diagnosis and treatment plan.
Aspect Ventures led the $10 million Series A round. BBG Ventures, LaunchCapital, iNovia, RiverPark Ventures, Ulu Ventures, Day One Ventures and Portfolia participated.
Rethink Impact led the Series A round, which will be used to grow Sempre's relationships with health plans and to make its service available to more patients.
CEO and neuroscientist Dr. Iftach Dolev on how the new device can bring a powerful tool to psychiatrists and neurologists alike.
The startup will use the money from Insight Venture Partners and Atomico for R&D, to further expand its reach in the MSK field and to grow its commercial team.
Through their partnership, the data and pictures requested by Grand Rounds on behalf of patients can be shared between imaging centers and medical facilities.
During an August 1 earnings call, Fitbit co-founder and CEO James Park highlighted additional ways the company plans to make money, such as through the selling of services like diagnostics and coaching.
In addition to the funding led by Greylock Partners, the startup also revealed a new feature that lets consumers pay their healthcare bills from their phone.
The Series B round, which Innovaccer will use to continue developing its InData platform, was led by Westbridge Capital. Lightspeed Ventures also participated.